Ex Parte CIMA et al - Page 13




          Appeal No. 1998-2813                                                        
          Application No. 08/463,203                                                  


          polymers listed in claim 24, or wherein the polymer includes a              
          biodegradable latex as required in claim 25.  Since we agree with           
          appellants, we will not sustain the examiner's rejection of                 
          claims 23/19, 24/19 or 25/19. 2                                             


               In view of the foregoing, the examiner's decision rejecting            
          claims 19, 31, 32/19 and 36/19 under 35 U.S.C. § 102(e) as being            
          clearly anticipated by Fink is affirmed.  As regards the                    
          examiner's rejection of claims 20, 22/20, 29, 30 and 33 through             
          35 under 35 U.S.C. § 102(e) as being anticipated by Fink or, in             
          the alternative, under 35 U.S.C. § 103 as being unpatentable over           
          Fink, we note that the examiner's decision has been sustained               
          with respect to claims 29 and 30, 33/32/19, 34/32/19 and                    
          35/34/32/19, but reversed as to claims 20, 22/20, 33/32/21,                 
          34/32/21 and 35/34/32/21.  The examiner's decision rejecting                
          claims 21, 22/21, 23 through 25, 32/21 and 36/21 under 35 U.S.C.            
          § 103 as being unpatentable over Fink has been reversed with                
          regard to claim 21 and all claims which depend from claim 21.               





               2 With respect to claim 23, while we see clear support in              
          claim 21 for "the walls" of claim 23, we find no proper                     
          antecedent basis for "the walls" in claim 19, from which claim 23           
          also depends.  During any further prosecution of this application           
          before the examiner, this issue should be addressed.                        
                                         13                                           





Page:  Previous  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  Next 

Last modified: November 3, 2007